Ghasemi Mahshid, Behnaz Faranak, Hajian Habibollah
Assistant Professor of Anesthesiology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Assistant Professor of Anesthesiology, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Anesth Pain Med. 2018 Apr 25;8(2):e63230. doi: 10.5812/aapm.63230. eCollection 2018 Apr.
Shivering during a surgery is common. Recently, Alpha-D-agonist dexmedetomidine has been used to control and prevent shivering during and after surgery. However, the anti-shivering effects of this drug in people are unknown with substance abuse. The purpose of this study was to investigate the anti-shivering effect of this drug in addicted individuals.
After obtaining the required criteria, the criteria were randomized in 2 groups, dexmedetomidine and normal saline (each group n = 30), and were matched in age and sex. The dexmedetomidine 0.5 mg/kg/h was given to one group and normal saline infusion was given to the other group as a placebo immediately after induction of anesthesia and before surgery for lower limb lesions. During the operation, patients were monitored for shivering as well as vital signs and arterial oxygen saturation. In addition, after surgery, patients were evaluated for clinical side effects.
The results showed that systolic blood pressure was significantly lower in the dexmedetomidine group at 30 minutes to 150 minutes after injection during the operation (P < 0.01). There was no significant difference between the 2 groups at the other times. In intra-group comparisons in both groups, diastolic pressure drop was significantly decreased to 90 minutes after surgery. In general, at other times in each group, diastolic pressure changes were not significant compared to preoperative. In between group comparisons, the mean heart rate was significantly lower in the dexmedetomidine group at 30 minutes and 60 minutes compared to the control group. In addition, at other times, its lower values were not significantly different with the control group. The 2 groups did not show significant differences in the number of breaths per minute or as the intra-group (P > 0.05), although, the average respiratory rate per minute in the dexmedetomidine group was lower. Decreased temperature of the tympanic curvature was significantly lower in the DEX group at 10 and 60 minutes after surgery than the control group (P < 0.001). Arterial oxygen saturation was more than 97% in both groups before and after operation, and no difference was observed between the 2 groups.
Prescribing dexmedetomidine during spinal anesthesia in patients with substance abuse can significantly decrease the incidence of shivering during surgery while not having adverse effects on hemodynamics of patients and can be used as a safe and effective drug for this purpose.
手术期间寒战很常见。最近,α-激动剂右美托咪定已被用于控制和预防手术期间及术后的寒战。然而,该药物在有药物滥用问题的人群中的抗寒战效果尚不清楚。本研究的目的是调查该药物在成瘾个体中的抗寒战作用。
在满足所需标准后,将符合标准的患者随机分为两组,右美托咪定组和生理盐水组(每组n = 30),并在年龄和性别上进行匹配。一组给予0.5mg/kg/h的右美托咪定,另一组在麻醉诱导后、下肢病变手术前立即给予生理盐水输注作为安慰剂。手术期间,监测患者的寒战情况以及生命体征和动脉血氧饱和度。此外,术后对患者进行临床副作用评估。
结果显示,术中注射后30分钟至150分钟,右美托咪定组的收缩压显著低于对照组(P < 0.01)。其他时间两组之间无显著差异。两组组内比较,术后90分钟舒张压下降显著。总体而言,每组其他时间的舒张压变化与术前相比无显著差异。组间比较,右美托咪定组在30分钟和60分钟时的平均心率显著低于对照组。此外,其他时间其较低值与对照组无显著差异。两组每分钟呼吸次数组间及组内均无显著差异(P > 0.0),尽管右美托咪定组每分钟平均呼吸频率较低。术后10分钟和60分钟,右美托咪定组鼓膜弯曲温度下降显著低于对照组(P < 0.001)。两组手术前后动脉血氧饱和度均大于97%,两组之间未观察到差异。
在有药物滥用问题的患者脊髓麻醉期间使用右美托咪定可显著降低手术期间寒战的发生率,同时对患者的血流动力学无不良影响,可作为一种安全有效的药物用于此目的。